Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Kimberly-Clark Corporation showed an optimistic performance in its first quarter for 2024, which was driven by its strategy to elevate its categories with breakthrough innovation and expand its markets.</li><li>This strategy helps the company to navigate effectively through the ever-changing external dynamics of today's new normal.</li><li>There were noted improvements in volume, and the company expressed confidence about the underlying volume momentum in the business.</li></ul>

Kimberly-Clark Corporation showed an optimistic performance in its first quarter for 2024, which was driven by its strategy to elevate its categories with breakthrough innovation and expand its markets.This strategy helps the company to navigate effectively through the ever-changing external dynamics of today's new normal.There were noted improvements in volume, and the company expressed confidence about the underlying volume momentum in the business.

Kimberly-Clark Corporation: What Is Their New Operating Model And Will It Impact The Bottom-Line? - Major Drivers

<ul><li>Kimberly-Clark's recent earnings for its fourth quarter and full year 2023 results showed both steady growth and challenges.</li><li>They are focused on elevating categories and expanding markets for growth, a strategy which is showing promising results.</li><li>The earnings call highlighted that the company had faced supply constraints that affected its market share.</li></ul>

Kimberly-Clark's recent earnings for its fourth quarter and full year 2023 results showed both steady growth and challenges.They are focused on elevating categories and expanding markets for growth, a strategy which is showing promising results.The earnings call highlighted that the company had faced supply constraints that affected its market share.

Kimberly-Clark Corporation: Optimized pricing and volume mix strategy could be a game changer? - Major Drivers

<ul><li>Kimberly-Clark Corporation delivered mixed results for the previous quarter, with revenues below the analyst consensus.</li><li>The strategic exit from the Brazil tissue business had an additional effect, reducing net sales by 100 basis points, primarily affecting Consumer Tissue and the Professional business.</li><li>Consumer Tissue reported 2% organic growth, with North America delivering a strong 4% organic growth, driven by robust demand for dry baths and towels.</li></ul>

Kimberly-Clark Corporation delivered mixed results for the previous quarter, with revenues below the analyst consensus.The strategic exit from the Brazil tissue business had an additional effect, reducing net sales by 100 basis points, primarily affecting Consumer Tissue and the Professional business.Consumer Tissue reported 2% organic growth, with North America delivering a strong 4% organic growth, driven by robust demand for dry baths and towels.

Kimberly-Clark Corporation: Is It The Market’s Hidden Gem? - Major Drivers

<ul><li>Kimberly-Clark delivered mixed results for the previous quarter, with revenues below analyst expectations but managed an earnings beat.</li><li>The company delivered strong organic growth across all segments.</li><li>Significant progress was made on margin recovery, leading to increased adjusted gross margin, operating profit, and earnings per share.</li></ul>

Kimberly-Clark delivered mixed results for the previous quarter, with revenues below analyst expectations but managed an earnings beat.The company delivered strong organic growth across all segments.Significant progress was made on margin recovery, leading to increased adjusted gross margin, operating profit, and earnings per share.

Kimberly-Clark Corporation: Winning the Race in Key Markets Worldwide? – Major Drivers

Value Investing

Vladimir Dimitrov, CFA

<ul>
<li>Kimberly-Clark's disappointing performance in recent years is hardly a surprise and does not make the company a bargain.</li>
<li>The short-term perspective on margins remains mixed, in spite of the management's optimism.</li>
<li>KMB could no longer support these activities, according to the company's management.</li>
</ul>


Kimberly-Clark's disappointing performance in recent years is hardly a surprise and does not make the company a bargain.
The short-term perspective on margins remains mixed, in spite of the management's optimism.
KMB could no longer support these activities, according to the company's management.


Kimberly-Clark: Short-Term Tailwinds, But Little Hope For The Long Run

United States

Kimberly-Clark Corporation is a global health and hygiene company that manufactures and provides consumer products. The Company's products include diapers, tissues, paper towels, incontinence care products, surgical gowns, and disposable face masks.  Kimberly-Clark's products are sold in countries around the world.

Kimberly Clark (KMB US)

Kimberly-Clark Corporation: What Is Their New Operating Model And Will It Impact The Bottom-Line? - Major Drivers

Kimberly-Clark Corporation showed an optimistic performance in its first quarter for 2024, which was driven by its strategy to elevate its...

Baptista Research

Kimberly-Clark Corporation: Optimized pricing and volume mix strategy could be a game changer? - Major Drivers

Kimberly-Clark's recent earnings for its fourth quarter and full year 2023 results showed both steady growth and challenges. They are focused on...

Baptista Research

Kimberly-Clark Corporation: Is It The Market’s Hidden Gem? - Major Drivers

Kimberly-Clark Corporation delivered mixed results for the previous quarter, with revenues below the analyst consensus. The strategic exit from...

Baptista Research

Kimberly-Clark Corporation: Winning the Race in Key Markets Worldwide? – Major Drivers

Kimberly-Clark delivered mixed results for the previous quarter, with revenues below analyst expectations but managed an earnings beat. The...

Baptista Research

Kimberly-Clark: Short-Term Tailwinds, But Little Hope For The Long Run

Kimberly-Clark's disappointing performance in recent years is hardly a surprise and does not make the company a bargain.

Vladimir Dimitrov, CFA